Leo Pharma Investigational Site

Los Angeles, California 90025

Use our guide to learn which trials are right for you!

We've found
4 trials
at this facility
Atopic Dermatitis Clinical Trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling, Phase III
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling, Phase III
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling, Phase II
Updated: 12/31/1969
Leo Pharma Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials